Litcius/Paper detail

Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibitor: Part II

Ruben G.G. Leenders, Shoshy Alam Brinch, Sven T. Sowa, Enya Amundsen-Isaksen, Albert Galera‐Prat, Sudarshan Murthy, Sjoerd Aertssen, Johannes N. Smits, Piotr Nieczypor, Eddy Damen, Anita Wegert, Marc Nazaré, L. Lehtiö, Jo Waaler, Stefan Krauß

2021Journal of Medicinal Chemistry23 citationsDOIOpen Access PDF

Abstract

induced dose-dependent biomarker engagement and reduced cell growth in the colon cancer cell line COLO 320DM.

Topics & Concepts

ADMEChemistryWnt signaling pathwayLead compoundIC50PharmacokineticsPharmacologySignal transductionBiochemistryCancer researchIn vitroBiologyWnt/β-catenin signaling in development and cancerCoagulation, Bradykinin, Polyphosphates, and AngioedemaCancer-related gene regulation
Development of a 1,2,4-Triazole-Based Lead Tankyrase Inhibitor: Part II | Litcius